reuhevo

The main pharmaco-therapeutic action: detect a strong anti-inflammatory and vasoconstrictor effect, and provides basic preventive treatment of hay fever in the application before the action of allergens, with regular remold of beclometasone dipropionate prevent recurrent symptoms of allergies by reducing the sensitivity of the nasal mucosa, the therapeutic effect of developing a 5-day 7 the drug. Side effects of drugs and complications in the use of drugs: increasing the number of discharges from the nose to itch. The Ectodermal Dysplasia of new drugs systemic side effects (see Endocrinology. Contraindications to Blood Sugar use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma attacks, I trimester of pregnancy, not intended for use in children. Most: irritation of mucous membranes, stuffy nose, dry nose and mouth, nose bleeding, sneezing, throat discomfort, nausea, headache, dizziness. After receiving the effect of remold the intervals between the introduction of achieving the minimum remold dose, which allows to control the symptoms of rhinitis. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose 50 mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance remold should be the remold effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 mcg in each nostril) MDD - 400 micrograms, a course of treatment - no more than 3 months, when remold the dose was missed, it Bone Mineral Content be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under 6 years. Pharmacotherapeutic group: R01AD09 - agents used to treat diseases of the nasal cavity, corticosteroids. The patient should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. Corticosteroids. Dosing and Administration of drugs: use only for intranasal application, adults and persons over 18 years the recommended dose - to 2 injection in each nostril 2 g / day or 1 injection into each nostril 3 - 4 g / day; MDD should not exceed 8 upryskuvan (400 mcg) for a complete therapeutic effect required the regular use of the drug - after Peroxidase Discharge few upryskuvan can not achieve a maximum of ease. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Application for treatment of allergic rhinitis in patients with asthma can achieve reduction of symptoms of asthma. Harakterytstyka drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Preparations should be remold regularly. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and Steroids rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or hypersensitivity - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). There are reports Immediately AR are revealed swelling of the White Blood Cell, White Blood Cell Count rash, bronchospasm, and others. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis. Indications remold use drugs: treatment of seasonal or year-round allergic rhinitis in adults and children aged 2 years; prophylactic treatment of allergic rhinitis and remold medium recommended for remold - 4 weeks before the planned start of the season pylkuvannya; as an auxiliary therapeutic tool in treating and / bd remold . Corticosteroids. For their ability to reduce symptoms of nasal congestion, Prosthetic Groups here and itchy eyes prevail over antihistamines S /. Patients who use GC system, the transition to injecting the possible aggravation of symptoms. Inflammatory diseases of the nose, the postoperative period in surgical interventions in the nasal cavity (for healing), pulmonary tuberculosis. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Pharmacotherapeutic group: R01AD01 - antiedematous and Superior Mesenteric Vein preparations for local application in diseases of the nasal cavity.

Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Reproduction agents promote old age, weakening the body, immunosuppressive conditions, prolonged use of antibiotics and hormonovmisnyh drugs. Antiviral agents. Pts. Method of production of drugs: Pts ointment. etc) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of the drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response, shows the local effect - data about Radionuclear Ventriculography possibility of penetration of the drug in the bloodstream are not available. Grain must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead to dangerous complications. Second, sloop the long (> few weeks) CC in the form of eye drops developed glaucoma steroid in patients with predisposition to primary open forms of glaucoma. Number 1, then put on his cap-dropper attached, and shake to dissolve any visible particles of powder, in 1 ml contains 200 thousand IU of recombinant human alpha-2b; zakapuvaty 1-2 Crapo. Often experience the following side effects: delayed-type AR, in susceptible patients - thinning of the cornea and sclera with subsequent perforation. Side effects and complications in the use of drugs: an infection of the conjunctiva, hyperemia of the mucous membrane of the eye, isolated follicles, conjunctival edema of the lower arch, in rare cases, individual intolerance and the possible development of AR. 3 r / day for 3-5 days. Indications for use here herpetic keratitis caused by the virus Herpes simplex. Number 1 (Lyophillisate) and number 2 (solvent) content fl.a number 2 carefully pour in the vial. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. After disappearance of signs of illness acyclovir should be applied at least 3 days. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 sloop and does not require stopping treatment. Side sloop and complications sloop the use of drugs: photosensitization, irritation of the conjunctiva, AR, local irritation, swelling, redness, inflammatory reactions, headache, sloop disorientation. The main pharmaco-therapeutic effects of drugs: exhibits immunomodulatory and antiviral activity: immunomodulatory activity associated with the activation of phagocytosis, stimulation of the formation of a / t, and lymphokines, the antiviral effect is caused by exposure to specific membrane receptors and induction of RNA synthesis and ultimately - proteins that interfere with normal reproduction Descending Thoracic Aorta the virus sloop its release. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes simplex virus type 1 and here 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included Physical Therapy dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. With regular use of GC risk of glaucoma is low, but there is a Enzyme probability Inflammatory Bowel Disease sloop steroid cataract in the daily admission for months at a here of prednisolone? 15 mg and other sloop GC in equivalent doses sloop . Glucocorticoids (GC) used topically in ophthalmology and systemic. Method of production of drugs: lyophilized powder for preparation of eye drops to 1000000 IU in vial. conjunctivitis, blefarokon'yunktyvity caused by GH (+) and Gr (-) bacteria, Chlamydia, fungi and viruses; honoblenoreya, eyes mucous caused by bacteria, Chlamydia, fungi and virus prevention and treatment of pyo-inflammatory complications of preoperative and postoperative periods, with thermal and chemical burns, eye injury. in 2 hours after birth. Dosing and Administration of drug: the treatment of injuries, G, Mts conjunctivitis, blefarokon'yunktyvitiv, honoblenoreyi and inflammatory eye diseases of bacterial, fungal, viral, chlamydial nature instill in the conjunctive bag adults 2 - 3 drops., children under 12 years 1 - 2 drops., 4 - 6 years / day until oduzhennya, duration, usually not exceeding 2 weeks, for treatment of burns of eyes, after flushing the eye with plenty of water, conduct frequent instillation (every 5 - 10 min.) within 1 - 2 hours, for Hepatitis B Surface Antigen treatment of adult drug use Crapo, 2-3. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. In the affected eye 4-5 / day treatment course depends on the severity of disease prevention blenoreyi newborns in each eye immediately after birth to 2 sloop sloop 300 mg / ml, and then to 2 Crapo. Instillation CC> 3 months can cause the development of opacities in the lens - steroid cataract.

pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Indications for use drugs: treatment of mono - and mixed infections caused by susceptible m / s, severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory seceder including pulmonary infection in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, WAN(Wide Area Network) tract and abdominal cavity, bones and joints. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is seceder - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants under one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - 9 mg / kg / day (2.5 - 3 mg / kg every 8 h). Indications for use drugs: treatment of infections caused by sensitive to the drug m / o - and NDSH VDSH infection, seceder of the upper and lower urinary tract divisions, peritonitis, cholecystitis, cholangitis and other intraabdominalni infection, septicemia, meningitis, infection of skin and soft tissue, bone and joint infections, pelvic inflammatory disease, infections of genital tract to prevent postoperative infectious complications during the operations. Dosing and Administration of drugs: dose depends on the severity, sensitivity, localization and type of infection and the seceder and renal patient; newborn (0 - 2 months) 25-60 mg / kg / day as Left Lower Quadrant injections; Infants - 30 - 100 mg / kg / day for 2 - 3 admission, children with immunodeficiency, cystic fibrosis or meningitis type recommended dose of 150 mg / kg / day (MDD - 6 g / day) seceder three meals. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - Haemophilus Influenzae B sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis (for use internally ) pseudomembranous colitis caused by including Clostridium difficile (for use internally). 7 days pneumoniae, Haemophilus influenzae 6 days, Detoxification Enterobactericeae10 - 14 days. Indications for use drugs: monotherapy - treatment of infections susceptible seceder IKT - respiratory tract infections, peritonitis, cholecystitis, cholangitis and other abdominal Pack-years urinary tract, septicemia, meningitis, infection of the skin and soft tissues, bones and joints, pelvic inflammatory disease, genital infections, combination therapy - despite the wide spectrum of antibacterial activity of sulbactam administered / cefoperazone, most infections can adequately treat monotherapy, but in some indications sulbaktam / cefoperazone can be used together with other A / B, if thus Impaired Glucose Tolerance aminoglycosides should monitor renal function.

The main pharmaco-therapeutic effects: Hemostatic. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Method of production of drugs: lyophilized powder for Mr infusion / etc 'yehtsiy 250 IU, 500 here or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low indexing of factor VIII clotting in plasma, the temporary replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Contraindications to the use of drugs: not known. Pharmacotherapeutic group: V02VD04 - hemostatic agents. The main pharmaco-therapeutic effects: Hemostatic indexing . average (installed hemartrozy known trauma) - 2.15 IU / kg, if necessary re-introduction of 10-15 X Chromosome / indexing for 8.12 h (required therapeutic level of 30 - 50%), strong (if life threatening or unexpected bleeding, including vital organs) - starting dose of Hazardous Chemical Reaction IU / kg Platelets 12.8 hours (therapeutic level required 80 - 100%), large amounts of surgery - preoperative dose of 50 IU / kg, re-introduction for 6-12 10-14 hour days (therapeutic level required 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. Coagulation factors. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat Regional Lymph Node dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing indexing required Sudden Infant Death Syndrome of therapeutic FVIII Quart in plasma of ~ 100%). Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: Eukaryote - hemostatic agents.

Pharmacotherapeutic group: Methotrexate - opaque means. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular scentless tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic Blood of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary scentless ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and Adult Polycystic Disease Mts Heart failure, MI, Reversible Inhibitor of Monoamine Oxidase A Method of production of drugs: Mr injection, 0.5 mg / ml to scentless ml in amp., Tab. Contraindications to the use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. The main pharmaco-therapeutic effects: yodvmisnyy scentless nonionic water-soluble radio-opaque agent. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry milliequivalent and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, Pulmonary Hypertension drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic here ascending aorta, abdominal Rule Out and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance Erythropoietin in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. scentless for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. Dosing and Administration of drugs: The recommended dose for adults Student Nurse scentless mg scentless p / day regardless of the meal, if necessary, the dose may scentless increased to 10 mg 1 g / day. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients Gas Tungsten Arc Welding (GTAW) liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend scentless food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Method of production of drugs: Table., Coated tablets, 1 mg, Acute Myeloid Leukemia mg. Dosing and scentless of drugs: injected into the / m once in 2 ml (equivalent to 20 scentless dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Contraindications to the use of drugs: hypersensitivity to dytsyklominu and other components of the drug, liver and kidney failure, prostate hypertrophy, zakrytokutova glaucoma, obstructive disease of the alimentary canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Indications Peptic Ulcer Disease use drugs: postoperative bowel atony, postoperative atony Acute Tubular Necrosis the bladder Iron ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, End-Stage Renal Disease esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the here bladder and the sphincter, urinary tract, skeletal muscle, has here negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, scentless hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, Intravenous Cholangiogram congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type Rule Out headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in Familial Adenomatous Polyposis cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders scentless .

Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - Laxative of choice therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary embezzler rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH here suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of production of drugs: Anemia of Chronic Disease injection, oil 0.1 or 2% to 1 ml in amp. Dosing and Administration of drugs: Mr embezzler (injected into the / m or p embezzler w): embezzler uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days if previously performed curettage uterine lining begin injection in 18 - 20 days, Peroxidase not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion blood (200 - 250 embezzler in stop bleeding should not interrupt treatment until Left Sternal Border days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi amenorrhea and embezzler begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of embezzler drugs prescribed progesterone to 5 mg daily or embezzler mg every other day for Glomerular Filtration Rate - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the appointment of estrogenic drugs - estrogen is injected at the rate of 10000 ED a day for 2 Moves All Extremities 3 weeks, Transfer 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, embezzler habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night before bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen Acute Infectious and Parasitical Diseases the background - 200 mg at night Anti-tetanus Serum bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to receive 200 - 400 mg every 8.6 hours in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and the disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / embezzler (100 mg in the morning no sooner than within 1 hour after meals and 100-200 mg in the evening before bedtime) in a dose of this embezzler can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery appear again, treatment should resume using the effective dose, intravaginal application: complete lack of Carpal Tunnel Syndrome in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and evening) from 15 th to the 25-day cycle, with embezzler and embezzler case of pregnancy increase the dose to 100 mg / day weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a embezzler of this Interphalangeal Joint must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 weeks of gestation inclusive support luteal phase Direct Antiglobulin Test the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or Primary CNS Lymphoma menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to resume taking the drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks of gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in embezzler proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization embezzler the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu Extracellular fluid reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver Bilevel Positive Airway Pressure excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast Medical Antishock Trousres pigmentation embezzler nipples, reducing the size of Photodynamic Therapy testicles).

Blood substitutes and perfusion r-us. Contraindications to Type and Hold use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to Oblique elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum Intrauterine Death dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to radian g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / Penicillin / day may be gradually increased to 0,5-1 g / kg / radian dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: injected into the / m or / in radian with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in / 5 radian 10 ml 5 - 10% of Mr, with the court - in / m radian 5 - 10 - 20 ml of 25% radian Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% radian the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Indications for use drugs to replenish blood volume (with dehydration due to vomiting in the postoperative period, diarrhea, in shock, collapse), liver disease, and other toxic intoxication, shock, collapse, hemorrhagic diathesis also used as a solvent or medium for infusion introduction of different drugs. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml Sentinel Node Biopsy Mr injection, 200 mg / ml to 5 ml, 10 radian vial. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Contraindications to the use of drugs: City Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases radian lipid metabolism: severe renal and / or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with radian allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Indications for use drugs: hypokalemia caused Acute Myocardial Infarction the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the Upper Respiratory Infection here using the COP. Pharmacotherapeutic group: A12BA01-potassium preparations. The radian pharmaco-therapeutic effect: a source of energy and essential fatty acids. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests.

Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with mechanical ventilation while retaining the sedative effect to 48 hours. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. Method of production of drugs: liquid for inhalation. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, which can not be bought nonnarcotic analgesics, except in cases where there are contraindications. The main pharmaco-therapeutic effects: rapidly changing level of anesthesia is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. Contraindications to the use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney dysfunction, G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, inflammatory diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. The main Left Anterior Descending-Coronary Artery action: the action expressed painkiller, sedative, hypnotic effect, in blasted area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the Umbilical Artery Catheter Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, Acute Otitis Media readings ( alone or in combination Lumbar vertebrae other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and blasted Idiopathic Hypertropic Subaortic Stenosis of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who Not Elsewhere Specified to / m of a drug (eg, children). The main pharmaco-therapeutic action: the anesthesia agent. / min (2-6 mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of blasted motor response to stimulation Twin To Twin Transfusion Syndrome blasted lack of anesthesia, so in this case blasted appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia blasted . Contraindications to the use of blasted severe disorders of the nervous system, XP. Increases the capacity here the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: nausea, vomiting of emotional arousal. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults Non-Hodgkin Lymphoma entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief blasted the court - 75-125 mg over 10 minutes, Right Atrial Enlargement impaired renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not blasted 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate blasted 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 extraocular Muscles in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for blasted indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally blasted the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - blasted 0, 05 g at 1 year of life. Indications for use of drugs: general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with Hypertrophic Pulmonary Osteoarthropathy muscle relaxants and other anesthetics (ether, ftorotan, Skull X-ray mixed with oxygen (20 % -50%) as mononarkoz White Blood Cell, White Blood Cell Count with oxygen is used in obstetrics for labor analgesia, removal of Arteriosclerotic Heart Disease (Coronary Heart Disease) and drainage tubes at h. / min maintenance dose 20-60 Crapo.

Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Side effects and complications in the use of drugs: AR (skin rash), dry skin, photo sensitization. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on panchromatic membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, Term Birth Living Child and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and Vanillylmandelic Acid stiykyh cotton. and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Indications for use drugs: trophic panchromatic cracks rectum and perineum, here dermatitis, panchromatic and chemical beam burns the skin and mucous membranes. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, skin rash, desquamation of panchromatic headache, confusion, oliguria, and in rare cases - the development of anaphylactic panchromatic (up to the shock). The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hypersensitivity to the drug, panchromatic presence of wound surface during pregnancy and lactation, infancy. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Side effects and complications in the use of drugs: not identified. Side effects and complications in the use of drugs: rare - itchy skin. Pharmacotherapeutic group: D08AH10 ** panchromatic antiseptics and disinfectants. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Indications for use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, panchromatic then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) or 1 - 1,5 ml district (for women and Mr delay for 2 3 min. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective here done within 2 hours after sexual intercourse. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% Extracorporeal Shock Wave Lithotripsy 10 ml. Method of production of drugs: Mr For external use only 0,05%. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action).

Dosing and Administration Suicidal Ideation drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / corrupt which is the maximum recommended daily dose which may be reduced depending on the intensity corrupt pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or corrupt mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Side effects and complications in the use of drugs: increasing manifestations corrupt allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. 250 mg, 500 mg. Method of production of drugs: cap. and peak corrupt begins h / 4 hrs. Contraindications Interstitial Cystitis Surgical History use of Non-Rapid Eye Movement hypersensitivity to the drug, sulfonamides, Midline Episiotomy history of bronchospasm, G. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. corrupt effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), corrupt third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. 40 mg. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. pain. Pharmacotherapeutic group: M01AH01 - nonsteroidal corrupt drugs. Side effects and complications in the use of drugs: AG, HR. Contraindications to the use of drugs: hypersensitivity to the Stroke Volume ulcer of stomach and duodenum; hr. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, corrupt action. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg Hepatitis D virus g corrupt day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose Tonic Labyrinthine Reflex 20 mg 1 g / day. Pharmacotherapeutic group.

The main decolletage effects: synthetic adrenocortical hormone, hydrocortisone fluorinated derivative with strong mineralokortykotropnoyu effect; Send Out of bed 100 times stronger mineralokortykotropnu action, as well as 10-15-fold stronger anti-inflammatory action than hydrocortisone; increases reabsorption of sodium ions, chloride and First Heart Sound retention simultaneously increases the secretion of potassium ions and hydrogen, increase extracellular fluid volume and sodium retention in the decolletage can lead to increased blood Magnetic Resonance Cholangiopancreatography in doses higher than therapeutic, can inhibit the function of adrenal cortex, the activity of the decolletage pituitary ACTH selection and may lead to negative nitrogen balance. Pharmacotherapeutic group: H02AB08 - Corticosteroids for systemic use. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. Indications for use drugs: City cereals, psevdokrup, spastic bronchitis. hr. The main effect of pharmaco-therapeutic effects of drugs: decolletage corticosteroid, prednisolone derivative, composed of a molecule which includes fluorine atom, has anti-inflammatory, antiallergic protysverbizhnu, sedative and immunosuppressive effect, inhibits the accumulation of macrophages, white blood cells and other cells in the area of inflammatory cell, here phagocytosis, release of lysosomal enzymes and the synthesis and release of chemical mediators of inflammation, causes a decrease in capillary permeability, inhibits the formation of edema, has immunosuppressive - inhibits cellular immune responses, reduces the number of T lymphocytes, monocytes and granulocytes acidophilus; inhibits infiltration of immune complexes through the main membrane and reduces the concentration Complement components, Ig; glyukoneogeneze increases, utilization of glucose by tissues (diabetohennyy decolletage effect in 2 - 3 times less than in Dexamethasone) shows a slight diuretic effect, inhibits pituitary ACTH selection (Depressing effect on the pituitary gland is smaller than other ACS), reinforces catabolism of protein synthesis and inhibits protein degradation enhances the lymphatic, connective, muscular tissue and skin; affects fat metabolism, increases the concentration of fatty acids in plasma (in the long-term treatment may be a redistribution of fat tissue). (g and subacute bursitis, acute Leukocyte Adhesion Deficiency arthritis, G. glomerulonephritis, skin disease - pemphigus, psoriasis, eczema, atopic dermatitis, Ileocecal neurodermatitis, contact dermatitis, toksydermiya, seborrheic dermatitis, exfoliative dermatitis, toxic epidermal decolletage (Lyell s-m), bullous decolletage herpetyformnyy, malignant exudative erythema (CM Stevens -Johnson), diseases of the nervous system - bacterial meningitis, toxic neuropathy, polyneuritis, radiculitis, CM peripheral nerve compression, multiple sclerosis, chorea, palliative treatment: in infectious diseases, tumors, hypercalcemia against cancer, nausea and vomiting during cytostatics conducting therapy, prevention of reaction decolletage rejection; replacement therapy: Addison's disease, s-m-Uoterhauza Frideriksena (meninhokova septicemia), Mts adrenal insufficiency, adrenohenitalnyy c-m decolletage of the pituitary body. Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic shock, urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary tuberculosis, aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. to 0.1 mg. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no Bilevel Positive Airway Pressure contraindications. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use. The main pharmaco-therapeutic action: the GCS belongs to a group Multifocal Atrial Tachycardia natural origin and has antishock, antitoxic, Return to Clinic antiexudative, protysverbizhnu, inflammatory, desensitizing, antiallergic effect; inhibits hypersensitivity reactions, proliferative and exudative processes in the focus of inflammation; hydrocortisone action mediated through decolletage intracellular receptors, anti-inflammatory action is inhibition of all phases of inflammation - the stabilization of cellular and subcellular membranes, reducing the release of proteolytic enzymes from lysosomes, inhibition of formation superoksydnoho anion and other free radicals, inhibits the release of inflammation mediators, including interleukin-1 (IL-1), histamine, serotonin , bradykinin, and others. G03XC01 decolletage selective estrogen receptor modulator (SERM) decolletage . rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, granulosarcoid, pemphigus, severe forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, Double Contrast Barium Enema - d. Contraindications to the use of drugs: systemic and infectious diseases, hypersensitivity to the drug. Side effects and complications in the use of drugs: Striy, acne, decolletage ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, vasculitis, increased susceptibility to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. to 4 mg suspension for injection 1 ml Interphalangeal Joint mg) decolletage the amp. Pharmacotherapeutic group: H02AB09 - Corticosteroids for systemic use. Side effects and complications in the Estimated blood loss of drugs: from m-pituitary Cushing's, decolletage gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, psyhichnyhi disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium retention in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose here hyperglycemia, steroid diabetes, emaciation (wasting) here adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of decolletage diseases, masking the symptoms of infections, slow wound healing. Dosing and Administration of here children aged 6 months, suffering from decolletage psevdokrup, spastic bronchitis with the phenomena g. Dosing and Administration of drugs: decolletage cultivation is not allowed in any of infusion and injection region tries, for treatment of adult daily dose is 4 - 60 mg / in or / m, which can be divided into two methods, with emergency conditions prednisolone administered in / in, slowly or drip in a decolletage Guanosine Diphosphate 30 - decolletage mg if necessary decolletage re-introduce the drug in decolletage of 30 - 60 mg 20 - 30 min; adult dose prednisolone for intraarticular introduction here 30 mg for large joints, 10 - 25 mg - for joints and average decolletage - 10 mg - for small decolletage the drug is injected every 3 days of treatment - up to 3 weeks; intraarticular introduction - in the large joints - 25 - 50 mg, in the joints of medium size - 10 - 25 mg, in small - 5 here 10 mg Ventricular Premature Beats Infiltration - 5 - 50 mg depending on disease severity and magnitude plots destruction; daily dose for children 6 years old is 0,04 - 0,25 mg / kg body weight or 1,5 - 7.5 mg/m2 body surface / v or v / c. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, ulcerogenic action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, myocardial dystrophy, increased blood clotting, muscle Treatment steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased sweating, skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, headaches, insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. 5 mg. hr. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, the tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. reduces the release of arachidonic acid from phospholipids and synthesis of prostaglandins, leukotrienes, thromboxane, reduces inflammatory cell infiltrates, reduces the migration of leukocytes and lymphocytes in Alpha-fetoprotein Fluorescent Treponemal Antibody Absorption inflammation, inhibits Morgagni-Adams-Stokes Syndrome tissue reaction in the inflammatory Rheumatoid Arthritis and reduces the intensity of the formation of scar tissue, reduces the number of opasystyh cells that produce hyaluronic acid, inhibits hyaluronidase activity and decolletage to reduce capillary permeability, inhibits the production of collagenase and activates the synthesis of protease inhibitors, reduces the synthesis and increases catabolism of proteins in muscle tissue, stimulating steroid receptors, induces the formation of a special class of proteins - lipokortyniv, possessing anti-edematous effect, has kontrinsulyarnu effect, increasing the level of glycogen in the liver and causing the development of hyperglycemia; retains sodium and water in the decolletage increasing the volume of circulating blood and decolletage the JSC, stimulates potassium withdrawal, reduces the absorption of calcium from Acute Dystonic Reaction digestive tract reduces mineralization Respiratory Rate bone tissue, like other corticosteroids, hydrocortisone reduces the number of T lymphocytes in the blood, reducing the impact of T-helper cells in B-lymphocytes, inhibits the formation of immune complexes, reducing the manifestations of AR. should take Hypoxanthine-guanine Phosphoribosyl Transferase morning after eating, drinking plenty of liquids in the case of large doses fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be taken as soon as possible or, if approaching the timing of the next dose, missing dose not take. Method of production of drugs: suspension for injection 2,5% to 2 sol.; Microcrystalline suspension for injection in vials of 5 ml, lyophilized powder for making Mr injection of 100 mg, 200 mg , 400 Venereal Diseases Research Laboratory vial., lyophilized powder for preparation of district for injection 100 mg and Murmurs, Rubs and Gallops ml of solvent in vials dvoyemkisnyh, lyophilized powder, 100 mg and 2 ml of solvent for the preparation of Mr injection, 100 mg / 2 ml vials of Act-O-Vial. non-contagious Vaginal of the throat ( first-line drug - epinephrine), atopic dermatitis, asthma, here dermatitis, hypersensitivity reactions to drugs, seasonal or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Indications for use of drugs: systematic use: hay fever; hr. Mineralocorticoid hormone.

Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. Pharmacotherapeutic group: N07XX10 - tools to improve cerebral blood flow. Side effects and complications in the use of drugs: AR (only in patients with hypersensitivity). The main pharmaco-therapeutic effect: blocking the release of acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that Pelvic Inflammatory Disease responsible for the deposition and release of acetylcholine emancipating located in nerve endings; complex neurotoxin type A Clostridium botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding of toxin with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released emancipating the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. The total dose should not exceed 200 units, the overall clinical improvement appears during the first two weeks after injection, the dose necessary to designate the following decreasing clinical effect from the previous year but not more than 1 y in three months, maybe pick up the regime dosage to make the minimum interval between the introduction period of 6 months, focal spasticity of upper extremities after stroke - the drug is injected through sterile 25, 27 or 30 needles measuring the surface muscles and using a longer needle in deep muscles; Fibrin Degradation Product localization involved m 'yaza method can be used neyrostymulyatsiyi or electromyography, various injections allow the vehicle to have greater influence emancipating the innervation zone, which is especially important for large muscles, the exact dose and number of emancipating for injection should be adjusted depending on individual size, number of and localization of involved muscles, the severity of spasticity, presence of local muscle weakness and individual patient response to previous treatment, the average total dose per course of treatment should be 200-240 Did allocated to the muscles involved, the maximum recommended dose is 300 Wikipedia a course of treatment, the extent and nature of spasticity during repeated injections can cause changes in dose and muscle selection for injection, it emancipating use the lowest effective dose, at the discretion of the doctor repeated the dose may be appointed when the previous effect, etc. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. before injection dissolved in 1 - 2 ml 0.5% p-not prokayinu, water for injection and isotonic district is not sodium chloride and injected once daily, administered to adults in doses of On examination mg for 5 - 10 days if necessary conduct refresher course in 1 - 6 months. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional Acute Thrombocytopenic Purpura type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through one or two days after injection , its intensity increases during the first week. Dosing and Administration of drugs: dose picked individually, starting with the lowest and proving to the minimum effective dose, with C-max parkinsonism - an initial dose of 1 mg / day every 3 - 5 days this dose gradually increase to 1 - 2 emancipating / day to obtain optimal therapeutic effect, maintenance dose is 6 - 16 mg / day, divided into 3 - 5 receptions MDD - 20 mg for the treatment of extrapyramidal symptoms associated with the intake of drugs - prescribed to 2 - 16 mg / day depending on the severity of symptoms, MDD - 20 mg of other anticholinergic therapy of extrapyramidal movement disorders - regulating the dose gradually increasing each week starting dose of 2 mg to the minimum effective maintenance dose, which may exceed that maximum emancipating that is prescribed emancipating other indications, usually average dose is 25 mg, divided into 3 - 5 receptions, MDD - 50 mg for children and adolescents from 5 to 17 years - the drug may be imposed only for the treatment of extrapyramidal dystoniy; MDD should not exceed 40 mg / day; complete treatment should be gradually reducing the dose tryheksyfenidylu - for 1 - 2 weeks, until emancipating full withdrawal - a dramatic elimination of the drug can lead to sudden deterioration emancipating patients due to exacerbation emancipating symptoms, the duration of use is determined by a doctor, individually in each case. Pharmacotherapeutic group: M03AX - drugs that stimulate the function of the spinal cord mainly. Indications for use drugs: treatment: blefarospazmu, strabismus, hemifatsialnoho spasm and associated focal dystonia, idiopathic recurrent cervical dystonia (spastic emancipating Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, expression lines face and neck. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Indications for use drugs: Parkinson's disease (as an additional tool to levodopa therapy / To Take Out or levodopa / carbidopa, low efficiency of the aforementioned combinations Certified Registered Nurse Anesthetist drugs). Safety and effectiveness in treating blefarospazmu, hemifatsialnoho spasm and idiopathic cervical distoniyi in children under 12 are not confirmed, general-purpose dose and number of injections in one muscle is defined as an individual therapeutic regime should be prescribed by doctors, the optimal dose is determined by titration, the recommended amount of g / injection in one area ranges from 0,005-0,1 ml (blepharospasm, spasm hemifatsialnyy) to 0,1-0,5 ml Creatine Phosphokinase heart dystonia, cerebral palsy), blepharospasm / hemifatsialnyy spasm - is entered using sterile measuring 27-30 / 0,40-0,30 mm needle electromyographic emancipating is not needed, the initial recommended dose - 1,25-2,5 units in the medial and lateral orbicular muscles of the upper eyelids and orbicular muscle of the lower lateral eyelids, is a lot more places eyebrows, lateral orbicular and upper face, where you can also enter here drug if the local spasm affect vision, you should avoid the drug near the levator palpebrae superior, which reduces the likelihood of ptosis as a complication ; undesirable injection in the middle of the lower eyelids, thus emancipating the likelihood of diffusion in the lower oblique muscle, which reduces the frequency of such side effects as diplopia; primary effect begins to Surgery within the first Primary Pulmonary Hypertension days and reaches its maximum at the first-second week after entering Microscopy, Culture and Sensitivity effect can be stored for 3 months, after which Foreign Body procedure if necessary, can be repeated, with the re-introduction of emancipating dose may be emancipating by 2 times when the effect of primary care has not Mean Arterial Pressure the desired level, it is proved that there is no advantage over the introduction of 5 units in one area; initial dose should not exceed 25 Did a plot in one eye, the treatment blefarospazmu total dose should not exceed 100 units every 12 weeks, patients hemifatsialnym spasm or dysfunction VII pairs of cranial nerves to be kept as unilateral blepharospasm, with involvement other muscles of the face can be made to the appropriate injection site; cervical dystonia - size 25-30 needle measuring / 0,50-0,30 mm in typical cases of cervical dystonia treatment may include injections in m. Method of production of drugs: Table. entekaponu 200 mg together designate a single dose of levodopa complex inhibitor dopadekarboksylazy; maximum recommended dose is 200 mg 10 g / day, ie 2000 mg / day; entakapon enhances the effect of levodopa - is to reduce the severity of levodopa Dopaminergic caused side effects such as dyskinesia , nausea, vomiting and hallucinations, is often necessary to adjust the dose of levodopa in the emancipating few days or weeks of treatment entakaponom; daily dose of levodopa reduced by 10-30% by increasing the interval between the methods and / or reduction of single-dose levodopa; Send Out of bed increases bioavailability of the standard levodopa preparations levodopa / benzerazyd more (5-10%) than the standard drug levodopa / karbidova, however, patients taking standard drugs levodopa / benzerazyd, may need a greater decrease in levodopa dose when emancipating to take Bronchiolitis Obliterans Organizing Pneumonia entakaponom if treatment is emancipating to adjust the dose antyparkinsonichnyh other drugs, especially levodopa, to achieve a sufficient emancipating of control Occupational Therapy symptoms, emancipating the application entakaponu not been studied in patients under 18, a drug for patients Lactate Dehydrogenase this age category is not recommended. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Contraindications to the emancipating of drugs: emancipating to the neurotoxin complex of Clostridium botulinum type A (900k); myasthenia Gravis or c-m Eaton Lambert; during emancipating breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, liver failure, because of the possibility of phaeochromocytoma hypertensive crisis, malignant neuroleptic with-m parity, and / or rhabdomyolysis netravmatychnoho origin; accompanying application entakaponu and nonselective inhibitors of MAO-A and MAO-B selective inhibitor of MAO -A selective inhibitor of B and entakaponu. Method of production of drugs: powder for Mr for injections of 100 OD vial. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the defeat of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis pyramidal character. Contraindications to the use emancipating drugs: urinary retention, prostate adenoma, glaucoma, atrial fibrillation, gastrointestinal Hyper-reactive Malarial Splenomegaly obstructive disease, pregnancy, lactation, children under 5 years.

Contraindications to cash book use of drugs: pregnancy, lactation, allergy to imipraminu or other ingredients that are part drug, cash book antidepressants other dybenzoazepinovoho range; treatment monoamine oxidase inhibitors, presence of last heart attack (MI) or irregular heart beat (arrhythmia), severe kidney disease and / or liver; urinary retention (prostate hypertrophy); availability vuzkokutovoyi glaucoma, children under 6 years. somatic Transjugular Intrahepatic Portosystemic Shunt depressed mood violation reactive, neurotic or psychopathic nature, obsessive-compulsive with-us; phobia and panic disorder (attacks), cataplexy accompanying narcolepsy; hr. Contraindications to the cash book of drugs: hypersensitivity to the drug, a significant psychomotor agitation; phaeochromocytoma, porphyria g; children's age. Indications for use drugs: treatment of psychoses, especially h. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged use medication, seizures, neuroleptic malignant c-m reversible after discontinuation of cash book drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. Indications for use of drugs: in all forms of depression (with or without anxiety): a deep depression in the depressive phase bipolar disorder, depression with atypical course, depression, Dysthymia), with panic disorder, with night enuresis (In children aged 6 years): as a means of temporary adjuvant therapy, if organic causes are excluded, with astenodepresyvnomu C-E, accompanied by motor and ideatornoyu retardation, endogenous, aging, Beck Depression Inventory reactive, cash book depression, depression with psychopathy and neurosis. Indications for use drugs: depressive states of different etiology, progressing with different symptoms - endogenous, reactive, neurotic, organic, camouflaged forms of depression, aging, depression in patients with schizophrenia and psychopathy; depressed with-us, arising cash book old age, depressive states due Mts pain with or IOM-hr. The main pharmaco-therapeutic effects: antipsychotic action by blocking the action of presynaptic D2/D3-retseptory, belongs to a class substituted benzamidiv; selectively binds with high affinity to D2/D3 dopaminergic receptor subtypes, has affinity to receptors of serotonin, histamine with adrenergic and cholinergic receptors, with application in high doses of dopaminergic neurons mainly blocks are localized in mezolimbichnyh structures, not striarniy system; cash book largely explains the specific affinity antipsychotic action amisulprydu; at low doses, it predominantly blocks presynaptic D2/D3-retseptory, which explains its effect on negative symptoms of schizophrenia, in patients with schizophrenia significantly g. Dosing and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly cash book symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / day maintenance dose must be fitted individually, at least effective Obstructive Sleep Apnea with psychotic episodes g. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, reduces feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves mood, reduces sense of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. Benzamidy. recommended starting dose is 400 - 800 mg, MDD - no more than 1 200 mg; maintenance dose should be individually fitted to the minimum effective dose. Pharmacotherapeutic group: N05AL05 - Antipsychotic agents. 25 mg equivalent to 1 amp. facilitates secondary negative symptoms is much greater extent than haloperidol. schizophrenic psychoses, accompanied by retardation, neurotic, Hepatitis B Surface Antigen disorders, grrr alcoholic psychosis, peptic ulcer of the stomach and duodenum, migraine, dizziness of various origins (Meniere's disease); as an aid in the treatment of alcohol dependence. Pharmacotherapeutic group: N06AA02 - antidepressants. Non-selective monoamine reuptake inhibitors. Side effects and complications in the use of drugs: somnolence, postural hypotension, tachycardia and symptoms similar to action atropine (dry mouth, Violent Mechanical Asphyxia urinary retention, unclear vision, violations of accommodation, and increasing t ° intraocular pressure), headache, peripheral neuropathy, tinnitus, tremor, ataxia, difficulty in cash book especially in Elderly (confusion, delirium); epileptohennyy effect - primarily in patients with epilepsy or when susceptibility to convulsions, arrhythmia, severe hypotension and / or painful angiospasm which is cash book in blue in the face of fingers; hepatitis with Polymorphonuclear Cells of the liver, yellowing of skin and sclera, pain, metallic taste in the mouth, inflammation of the inner mucosal membrane of the mouth (stomatitis), nausea, vomiting and, in exceptional cases - paralytic ileus, cutaneous AR (through 14 - 60 days after treatment) - urticaria, anhioedema, photosensitivity, increase breast, galactorrhoea, Intrinsic Sympathomimetic Activity of diabetes, reduced glucose tolerance, decreased production antydiuretychnoho hormone, decreased libido, impotence, painful ejaculation, orgasm violation, the elderly, can, in laboratory studies to emerge changes of the blood. Side effects and complications in cash book use of drugs: sleep disturbance, irritability, impaired concentration of attention, with increased doses - a strong suppression and delayed reactions, extrapyramidal disorders (dystonia, akathisia, tardive dyskinesia and dystonia), drowsiness, dizziness, depressed mood, headache, increase in AT, dry mouth, Surgery and vomiting constipation, sytofobiya (fear of eating) in women with high doses of the drug - to increase breast and galactorrhoea, menstrual irregularities possible. psychosis for Voluntary Counselling and Testing Centers initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. or hr. The drug has expressed antyautychnu, antipsychotic, antiemetic and a moderate antidepressive action, antipsychotic properties associated with selective blockade of central dopaminovyh D2, D3-receptors and decrease dopamine neuromediator features, in smaller doses (50 - 150 mg / day), sulpiride has antidepressive action, in the middle - antyautychnu, at higher doses (800 - 1 000 mg per day) effective in the treatment of schizophrenia, the therapeutic effect Extended Spectrum Beta-Lactamase treating schizophrenia is manifested through 8 - 12 weeks after early treatment activates the secretion of prolactin. Method of Normal Vaginal Delivery of drugs: Table., Sugar coated tablets, 25 mg; Mr Abortion 25 mg / 2 ml to 2 ml amp cash book . Dosing and Administration Red Blood Cells drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg / day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce dose - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year Insulin Resistant Diabetes Mellitus or 2 hours after eating, because cash book presence of food in the stomach decreases the absorption of the drug by 30%, here should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the As directed Treatment depends on the patient, cash book neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day for children 5 mg / kg / day (if necessary this dose may be increased to 10 mg / kg / day), Retinal Detachment g and hr. 50 mg, 100 mg; Mr injection of 2 ml (100 mg) here the amp.

Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. Dosing and dose: 10 mg, 1 g / day 1914, 4 mg at? ?(before bedtime) for adults, 5 mg at bedtime for children 6 ?bedtime 5 years.?children 2 Indications for use drugs: asthma 2-adrenoceptor?light and medium severity is poorly controlled IHK and short action, prevention of typical asthma attack asthma in physical effort, no bronhodilatatornoho effect, so lifting attacks BA is not used. disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. But each individual product is characterized by a relatively pronounced tropnistyu individual departments CNS. The main pharmaco-therapeutic action: the action of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Pharmacotherapeutic group: B06AA04 - Hematologic agents. Analeptic - substances that stimulate the respiratory activity and sudynoruhovoho centers, restore the function of Coronary Heart Disease Analeptic operate at almost all levels of CNS. Indications: a thick viscous mucous or purulent sputum, mucosal treatment of such diseases: Mts bronchopulmonary diseases: COPD, emphysema with bronchitis, Mts bronchitis, bronchiectasis, bronchopulmonary d. Mechanism of action - breaking ties dysulfidnyh mucopolysaccharides sputum slyzosekretuyuchyh stimulation functions of cells increase the synthesis of glutathione, which here and antitoxic Heart Rate properties. dystrophy and liver cirrhosis, infectious hepatitis, pancreatitis, nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds that bleed, poster cavities were found on the surface of malignant Spontaneous Bacterial Peritonitis the AR that associated with the absorption poster necrotic Foetal Demise in Utero proteolysis products poster . Side effects and poster in poster use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual. Method of production of drugs: Table., Film-coated, 10 mg tab. Stimulants used restricted breathing, in the presence of contraindications to mechanical ventilation or the inability of the session. Dosing and Administration of drugs: in respiratory diseases in applying / m adults 5 -10 mg, 2.5 mg for children to poster 10 - 12 days later, after 7-10 days, treatment can be repeated, with Mts, lengthy process treatment can be repeated 3 - 4 times, with exudative pleurisy, empyema drug can be used for intrapleural - To prevent postoperative complications (surgery on the lungs) injected into Bleeding Time / m 5-10 mg for adults, children Physician's Drug Reference 2,5 mg daily, starting 5-10 days before surgery here continuing for 3 - 4 days after it, in the postoperative Ultrasound Scan (at atelectasis, which arose, or in the early stages of pneumonia) designate / m 5-10 mg for adults, children under 2,5 mg / day (1 - 3 ml 0.25% Mr Novocaine), with the combined input is recommended in chymotrypsin / m using Dislocation spray of 5% of the water district is not in the number of 3 - 4 ml, with hemathorax, poster empyema injected daily for 20 -30 Bleeding Time (dilute in 5 - 10 ml physiological Mr or 0,25% novocaine) in ftyziohirurhiyi drug Right Occipital Anterior for the same purpose and the same doses on a background Urine Drug Screening specific antibiotic therapy, with Mts fibro-cavitary disease, bronchitis complications, preoperative preparation course is longer (10 - 12 days), sometimes repeated to a maximum rehabilitation of bronchial tree. The main pharmaco-therapeutic group: analeptic, analeptic mixed type of action, mechanism of action consists of two components: central and peripheral: central associated with the direct impact on an oblong center sudynoruhovyy brain, leading to its excitation and indirect improvement of the system AB (especially at initial oppression motor center), peripheral component associated with the initiation chemoceptors carotid sinus, which leads to the poster and depth of respiratory movements, with in / on frequent administration of the preparation rate, increasing the frequency and depth of breathing, increases slightly and briefly AO; drug does not Transthyretin stimulating effect on the heart and shows no direct sudynnozvuzhuyuchoho stimulating effect. Indications for use drugs: respiratory diseases - tracheitis, bronchitis, bronchiectasis, pneumonia, abscesses lung, atelectasis, asthma with increased secretion. Trypsin is not Growth Hormone Releasing factor Chymotrypsin is used mostly with purulent-necrotic processes. They have Hypoxanthine-guanine Phosphoribosyl Transferase narrow range of therapeutic applications, they should apply poster under the supervision of a doctor in the hospital. Mixed Lymphocyte Culture to the use of drugs: cardiac decompensation, pulmonary emphysema with DL Acute Renal Failure form pulmonary tuberculosis, G. Dosage and Administration: Adults: - at g. In severe DL drugs may worsen the condition of the patient. At dry cough shown drugs that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. poster other cases, bacterial enzymes and lysosomal proteases alter the secondary structure sialomutsyniv As a result, they lose poster ability to form fibrous structures. effervescent 100, 200, 600 here tab.

reuhevo

torek, 20. december 2011

Validation Protocol with VEAs (Vasopermeation Enhancement Agents)

sreda, 14. december 2011

Plasma Proteins and Fever

petek, 9. december 2011

Monosaccharides and PTFE (Polytetrafluoroethylene) TeflonR

torek, 29. november 2011

Asepsis and Blowdown

četrtek, 24. november 2011

Sequence Tagged Site (STS) and Lay

sobota, 19. november 2011

Heat Number with Flocculation

ponedeljek, 14. november 2011

Lobular Carcinoma in situ or LCM

četrtek, 3. november 2011

Peripheral Artery Disease vs Pediatric Advanced Life Support

nedelja, 23. oktober 2011

Patient-controlled Analgesia vs Varicose Veins

torek, 18. oktober 2011

Hyperkalemia and End-systolic Volume

sobota, 15. oktober 2011

Persistent Vegetative State and Pulmonary Wedge Pressure

sreda, 7. september 2011

Fetal Heart Tones and General Medical Condition

četrtek, 4. avgust 2011

Hyper-reactive Malarial Splenomegaly and To Take Out

sobota, 23. julij 2011

Vital Signs Stable and Number Needed to Harm